This Edition
ARTICLE | Clinical News
ALRN-6924: Phase I started
WIR Staff
March 2, 2015 8:00 AM UTC
Aileron began a dose-escalation, U.S. Phase I trial to evaluate ALRN-6924 in 100-150 patients. ...